GNPX
Genprex Inc
NASDAQ: GNPX · HEALTHCARE · BIOTECHNOLOGY
$0.98
+12.07% today
Updated 2026-04-30
Market cap
$8.41M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-17.40
Dividend yield
—
52W range
$1 – $55
Volume
1.1M
Genprex Inc (GNPX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-338.70%
ROA
-135.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $0.00 | $-1.07M | — | — | — |
| 2016 | $0.00 | $-4.13M | — | — | — |
| 2017 | $0.00 | $-3.31M | — | — | — |
| 2018 | $0.00 | $-12.37M | — | — | — |
| 2019 | $0.00 | $-10.65M | — | — | — |
| 2020 | $0.00 | $-17.94M | — | — | — |
| 2021 | $0.00 | $-20.66M | — | — | — |
| 2022 | $0.00 | $-23.74M | — | — | — |
| 2023 | $0.00 | $-30.86M | — | — | — |
| 2024 | $0.00 | $-21.11M | — | — | — |
| 2025 | $0.00 | $-16.23M | — | — | — |